Genomics of chronic kidney transplant failure study
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a candidate for a kidney transplant (from a living or deceased donor).
- You are between 18 and 75 years old.
- You can understand and give written informed consent.
- You speak English or can understand the study requirements.
- You are not receiving a transplant from a living donor if your immune system is already highly sensitized against that donor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how genes affect kidney transplant outcomes. It asks you to give extra blood, urine, stool, and kidney tissue samples over time, so researchers can learn more about why some transplants work better than others.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
Hear when a new Kidney Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.